Showing posts with label Pulmonary MALT Lymphoma. Show all posts
Showing posts with label Pulmonary MALT Lymphoma. Show all posts

Thursday, December 27, 2012

Pulmonary mucosa-associated lymphoid tissue lymphoma coexisting with intratumoral tuberculosis.


Pulmonary mucosa-associated lymphoid tissue lymphoma coexisting with intratumoral tuberculosis.


Nov 2012

Source

Department of Hematology, Eiju General Hospital.

Abstract


A mass in the right upper lobe of the lung was observed in a chest X-ray examination of a 66-year-old woman. Pathological examination of the lung biopsy revealed a mucosa- associated lymphoid tissue (MALTlymphoma within the lesion. A systemic survey demonstrated no other lesions, and the patient was diagnosed as having a solitary pulmonary MALT lymphoma (Stage IE). After 9 months of careful monitoring, progressive enlargement of the lung tumor and involvement of right hilar lymph nodes were observed using positron emission tomography-computed tomography. Therefore, surgical resection of the right upper lobe and right hilar lymph nodes was performed, and coexistence of MALT lymphoma with tuberculosis was identified by pathological investigations. The association of chronic inflammation with the development of MALT lymphomas has been widely accepted. In the present case, pulmonary tuberculosis may have played a role in the pathogenesis of pulmonary MALT lymphoma.

Wednesday, November 21, 2012

A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis.


A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis.


Aug 2012

Source

Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea School of Medicine, Bucheon, Korea.

Abstract


Pulmonary mucosa-associated lymphoid tissue-derived (MALTlymphoma is a rare disease. This disorder is considered to be a model of antigen-driven lymphoma, which is driven either by autoantigens or by chronic inflammatory conditions. Low-gradeB-cell MALT lymphoma may develop from a nonneoplastic pulmonary lymphoproliferative disorder, such as lymphocytic interstitial pneumonitis (LIP). A recent estimate predicts that less than 5% of LIP patients acquire malignant, low-grade, B-cell lymphoma. In Korea, there has been no previous report of malignant low-grade, B-cell lymphoma, acquired from LIP. Here, we present the case of a patient with LIP that developed into pulmonary MALT lymphoma, six years after diagnosis.